CBD Oral Solution for Social Anxiety Disorder

"The age range for qualified applicants of this specific trial is 18 to 75. There are 111 trials available specifically for those under the legal age and 273 studies that cater to patients over 65 years old."

"This clinical trial, sponsored by EmpowerPharm Inc., necessitates the recruitment of 225 participants that meet its inclusion criteria. Recruitment efforts will be conducted at two sites: EPI-CBD-001 in Memphis Tennessee and EPI-CBD-001 Site in Rochester California."

"This clinical study is looking to enrol 225 individuals who suffer from phobia and social anxiety, ranging in age between 18 - 75. All participants must meet the following prerequisites: Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) SAD diagnosis should be predominant; LSAS score needs to exceed 70 points; any physical health abnormalities need to be absent based on an exam, ECG or lab tests results; female candidates have to test negative for pregnancy while also agreeing to a reliable contraception method; male subjects too have accept use highly effective birth control methods. Finally, all applicants are expected to read through the informed consent"

"At present, this experiment is running out of a total of 20 medical centres. While Memphis, Rochester and Encino are among the locations involved, there are 17 other sites to choose from. Those interested in participating should select the closest site available to them so as to minimize their travel obligations."

"That is correct. According to clinicaltrials.gov, this trial was first published on October 1st 2022 and has recently been updated on the 26th of October 2022. The study seeks 225 participants from a total of 20 different research sites."

"There is some research data indicating the safety of Cannabidiol (CBD) Oral Solution 300 mg/day, thus this medication recieved a rating of 2."